ArticleResearch square2026

Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial.

Sufia Dadabhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.